Clinical epidemiology of venous thromboembolic disease : Results of a French Multicentre Registry.
Objective Between July 1992 and December 1994,16 French hospital centres, mainly cardiological, participated in a non-controlled observational study on venous thromboembolic disease.
The objective of this survey was to collect data concerning the current status of pulmonary embolism and deep venous thrombosis.
Patients During this period, 547 patients were included : 446 with deep venous thrombosis and 387 with pulmonary embolisms.
Results Mean age of patients was 63 ± 21 years.
There were no significant differences between the sexes.
Pulmonary embolism and deep venous thrombosis tended to occur more frequently during the autumn and winter.
In 30% of cases, prior deep venous thrombosis or pulmonary embolism was noted.
No cause was found for the condition in 47% of cases.
Ultrasound (echocardiography and/or venous ultrasound) was the most frequently requested investigation.
Intravenous heparin remains the most widely used treatment (76%). Oral anticoagulation was begun before day 3 in less than 31% of cases.
Thrombolytic treatment was used in 20% of pulmonary embolism cases, but was rarely prescribed for deep venous thrombosis (2.2%). The hospital recurrence rate (12/547 cases) was fairly low.
The search for occult malignancy, performed in 48% of cases, seems to remain one of the major concerns of physicians.
The combined pulmonary embolism and deep venous thrombosis mortality rate was 4.4%, while the death rate for pulmonary embolism alone was 6.2%.
Mots-clés Pascal : Thromboembolie, Embolie pulmonaire, Thrombose, Veine profonde, Analyse coût efficacité, Economie santé, Anticoagulant, Chimiothérapie, Epidémiologie, Traitement, Homme, Appareil circulatoire pathologie, Vaisseau sanguin pathologie, Appareil respiratoire pathologie, Veine pathologie
Mots-clés Pascal anglais : Thromboembolism, Pulmonary embolism, Thrombosis, Deep vein, Cost efficiency analysis, Health economy, Anticoagulant, Chemotherapy, Epidemiology, Treatment, Human, Cardiovascular disease, Vascular disease, Respiratory disease, Venous disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0283976
Code Inist : 002B12B03. Création : 15/07/1997.